ORRAF(ORRAF)
ORRAF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.17B | $2.23B | $2.33B |
| Low | $2.06B | $2.11B | $2.21B |
| High | $2.25B | $2.31B | $2.42B |
| EBITDA Avg | $236M | $243M | $254M |
| Low | $224M | $230M | $241M |
| High | $245M | $251M | $263M |
| EBIT Avg | $145M | $149M | $156M |
| Low | $137M | $141M | $148M |
| High | $150M | $154M | $161M |
| Net Income Avg | $153M | $178M | $191M |
| Low | $142M | $166M | $178M |
| High | $160M | $186M | $199M |
| EPS Avg | $0.11 | $0.13 | $0.14 |
| Low | $0.11 | $0.12 | $0.13 |
| High | $0.12 | $0.14 | $0.15 |
| Analysts (Rev / EPS) | 12 / 1 | 5 / 1 | 10 / 1 |